Only very recently, Mangoni et al. have shown that pretreatment with Olaparib, Iniparib or Veliparib, three PARP1 inhibitors, is able to induce a significant radiosensitization in different soft tissue sarcoma cell lines (Mangoni et al. 2018). Here, PARP1 is linked to soft tissue sarcoma.